The DOI matches its Crossref record; 167 of the 171 references it cites were found in a registry or an index.
The PI3K/AKT pathway in obesity and type 2 diabetes
Open accessAbstract
Obesity and type 2 diabetes mellitus are complicated metabolic diseases that affect multiple organs and are characterized by hyperglycaemia. Currently, stable and effective treatments for obesity and type 2 diabetes mellitus are not available. Therefore, the mechanisms leading to obesity and diabetes and more effective ways to treat obesity and diabetes should be identified. Based on accumulated evidences, the PI3K/AKT signalling pathway is required for normal metabolism due to its characteristics, and its imbalance leads to the development of obesity and type 2 diabetes mellitus. This review focuses on the role of PI3K/AKT signalling in the skeletal muscle, adipose tissue, liver, brain and pancreas, and discusses how this signalling pathway affects the development of the aforementioned diseases. We also summarize evidences for recently identified therapeutic targets of the PI3K/AKT pathway as treatments for obesity and type 2 diabetes mellitus. PI3K/AKT pathway damaged in various tissues of the body leads to obesity and type 2 diabetes as the result of insulin resistance, and in turn, insulin resistance exacerbates the PI3K/AKT pathway, forming a vicious circle.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“AKT activation leads to increased glucose transporter 4 (GLUT4) expression and translocation, ultimately leading to increased glucose uptake.”
From Non-Diabetic Hypoglycemia: Evaluation and Management in Adults (2025) · cites this paper as [48]
The cited source says what the claim attributes to it.
In the citing paper
“PI3K is an enzyme that activates protein kinase B (AKT), which regulates glucose metabolism, among other intracellular functions [48].”
From Non-Diabetic Hypoglycemia: Evaluation and Management in Adults (2025) · cites this paper as [48]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
mTOR Signaling in Growth Control and Disease
Laplante, M., & Sabatini, D. M. (2012) · Cell · doi:10.1016/j.cell.2012.03.017 · Cited by 8,509 · cited 1×
“AKT-mediated mTORC1 activation regulates a number of downstream effectors proteins through phosphorylation, including the well-characterized effectors p70 ribosomal S6 protein kinase-1 (S6K1) and eukaryotic translation initiation factor-4E (eIF4E)binding protein-1 (4E-BP1), to increase protein synthesis [43, 44].”
BackgroundPhosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
Sarbassov, D. D., Guertin, D. A., Ali, S. M., & Sabatini, D. M. (2005) · Science · doi:10.1126/science.1106148 · Cited by 6,216 · cited 1×
“First, phosphorylation of the threonine 308 (AKT1) in the kinase domain by phosphoinositide-dependent protein kinase 1 (PDK1) initiates the activation process [19], subsequent phosphorylation at serine 473 (AKT1) in the carboxy-terminal regulatory domain through mTOR complex 2 (mTORC2)[17, 20], which is activated by a…”
BackgroundAKT/PKB signaling: navigating downstream
Manning, B. D., & Cantley, L. C. (2007) · Cell · doi:10.1016/j.cell.2007.06.009 · Cited by 6,115 · cited 1×
“AKT regulates two processes by glycolysis Glucose 6-phosphate and glycogen synthase kinase 3 (GSK3) to produce cellular energy via glycolysis and promotes glycogen production by inhibiting [30].”
BackgroundMechanisms linking obesity to insulin resistance and type 2 diabetes
Kahn, S. E., Hull, R. L., & Utzschneider, K. M. (2006) · Nature · doi:10.1038/nature05482 · Cited by 5,448 · cited 1×
“In obese subjects, excess levels of circulating FFAs, which are caused by a blunted response of adipose tissues, impairs the function of β cells [150].”
BackgroundInhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
Cross, D. A. E., Alessi, D. R., Cohen, P., Andjelkovich, M., & Hemmings, B. A. (1995) · Nature · doi:10.1038/378785a0 · Cited by 5,244 · cited 8×
“In the feeding state, SREBP-1c is regulated by four pathways: activated AKT stimulates liver X receptor (LXR), which is require for SREBP-1c transcription [64]; activated AKT stimulates mTORC1 to activate SREBP-1c transcription, and mTORC1 also inhibits Lipin-1, which decreases the half-life of nuclear SREBP-1c [65, 6…”
BackgroundInfluentialAKT/PKB Signaling: Navigating the Network
Manning, B. D., & Toker, A. (2017) · Cell · doi:10.1016/j.cell.2017.04.001 · Cited by 3,772 · cited 2×
“Similar phosphorylation events are observed at corresponding residues in AKT2 (T309 and S474) and AKT3 (T305 and S472) [22].”
BackgroundRole of leptin in the neuroendocrine response to fasting
Ahima, R. S., Prabakaran, D., Mantzoros, C., Qu, D., Lowell, B., Maratos-Flier, E., & Flier, J. S. (1996) · Nature · doi:10.1038/382250a0 · Cited by 3,117 · cited 1×
“In the presence of persistent excess energy availability, leptin signalling activates other pathways, such as STAT3 or SH2-containing tyrosine phosphatase, to predominantly regulate food intake in POMC neurons [90, 113, 119].”
BackgroundAlessi, D. R., James, S. R., Downes, C. P., Holmes, A. B., Gaffney, P. R. J., Reese, C. B., & Cohen, P. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00122-9 · Cited by 2,874 · cited 1×
“First, phosphorylation of the threonine 308 (AKT1) in the kinase domain by phosphoinositide-dependent protein kinase 1 (PDK1) initiates the activation process [19], subsequent phosphorylation at serine 473 (AKT1) in the carboxy-terminal regulatory domain through mTOR complex 2 (mTORC2)[17, 20], which is activated by a…”
BackgroundEndoplasmic reticulum stress and the inflammatory basis of metabolic disease
Hotamisligil, G. S. (2010) · Cell · doi:10.1016/j.cell.2010.02.034 · Cited by 2,802 · cited 1×
“Chronic metabolic inflammation and endoplasmic reticulum (ER) stress also impair hepatic insulin-AKT signalling and subsequently causes insulin resistance [106, 107].”
BackgroundHealth and economic burden of the projected obesity trends in the USA and the UK
Wang, Y. C., McPherson, K., Marsh, T., Gortmaker, S. L., & Brown, M. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60814-3 · Cited by 2,775 · cited 1×
“The prevalence of obesity has grown at an alarming rate although specific public health policies and treatment efforts have been developed to resist the obesity epidemic [1], potentially leading to increased numbers of patients affected by complications of obesity, such as the most devastating type 2 diabetes mellitus…”
BackgroundDeFronzo, R. A., Ferrannini, E., Groop, L., Henry, R. R., Herman, W. H., Holst, J. J., Hu, F. B., Kahn, C. R., Raz, I., Shulman, G. I., et al. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.19 · Cited by 2,611 · cited 1×
“Unfortunately, these treatments currently cannot ensure long-term glycaemic control or reverse the progress [4].”
BackgroundWhat we talk about when we talk about fat
Rosen, E. D., & Spiegelman, B. M. (2014) · Cell · doi:10.1016/j.cell.2013.12.012 · Cited by 2,373 · cited 11×
“In the feeding state, SREBP-1c is regulated by four pathways: activated AKT stimulates liver X receptor (LXR), which is require for SREBP-1c transcription [64]; activated AKT stimulates mTORC1 to activate SREBP-1c transcription, and mTORC1 also inhibits Lipin-1, which decreases the half-life of nuclear SREBP-1c [65, 6…”
BackgroundInfluentialAdult pancreatic β-cells are formed by self-duplication rather than stem-cell differentiation
Dor, Y., Brown, J., Martinez, O. I., & Melton, D. A. (2004) · Nature · doi:10.1038/nature02520 · Cited by 2,219
Mitochondrial dysfunction and type 2 diabetes
Lowell, B. B., & Shulman, G. I. (2005) · Science · doi:10.1126/science.1104343 · Cited by 2,070
Activation of a metabolic gene regulatory network downstream of mTOR complex 1
Düvel, K., Yecies, J. L., Menon, S., Raman, P., Lipovsky, A. I., Souza, A. L., Triantafellow, E., Ma, Q., Gorski, R., Cleaver, S., et al. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.06.022 · Cited by 2,020 · cited 1×
“The substrate SREBP, which regulates fatty acid synthase and cholesterol-related genes [18, 61], and FOXO1, which regulates lipolysis by controlling the expression of adipose triglyceride lipase (ATGL) [62], are primary substrates for AKT-mediated lipid metabolism [63].”
BackgroundDisruption of IRS-2 causes type 2 diabetes in mice
Withers, D. J., Gutierrez, J. S., Towery, H. H., Burks, D. J., Ren, J., Previs, S. F., Zhang, Y., Bernal, D., Pons, S., Shulman, G. I., et al. (1998) · Nature · doi:10.1038/36116 · Cited by 1,775
The emerging mechanisms of isoform-specific PI3K signalling
Vanhaesebroeck, B., Guillermet-Guibert, J., Graupera, M., & Bilanges, B. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2882 · Cited by 1,767 · cited 1×
“Meanwhile, RTKs and GPCRs also activates Ras to subsequently activates PI3K [14].”
BackgroundAbsence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity
Um, S. H., Frigerio, F., Watanabe, M., Picard, F., Joaquin, M., Sticker, M., Fumagalli, S., Allegrini, P. R., Kozma, S. C., Auwerx, J., et al. (2004) · Nature · doi:10.1038/nature02866 · Cited by 1,677 · cited 1×
“[138], activation of S6K1, a downstream effector of mTORC1, in hypothalamic neurons leads to hepatic insulin resistance because it decreases the stimulation of IRS-1 and AKT.”
BackgroundDirect Regulation of the Akt Proto-Oncogene Product by Phosphatidylinositol-3,4-bisphosphate
Franke, T. F., Kaplan, D. R., Cantley, L. C., & Toker, A. (1997) · Science · doi:10.1126/science.275.5300.665 · Cited by 1,462 · cited 1×
“Activated Class I PI3K phosphorylates the substrate phosphatidylinositol 4,5-biphosphate (PIP2) to form phosphatidylinositol 3,4,5-triphosphate (PIP3) on intracellular membranes, subsequently recruiting signalling proteins, including AKT[15].”
BackgroundKahn, S. E., Prigeon, R. L., McCulloch, D. K., Boyko, E. J., Bergman, R. N., Schwartz, M. W., Neifing, J. L., Ward, W. K., Beard, J. C., & Palmer, J. P. (1993) · Diabetes · doi:10.2337/diab.42.11.1663 · Cited by 1,405
Fruman, D. A., Meyers, R. E., & Cantley, L. C. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.481 · Cited by 1,382 · cited 1×
“PI3Ks are a family of lipid kinases that phosphorylate phosphatidylinositol, which is a component of eukaryotic cell membranes [10].”
BackgroundmTOR Complex 1 Regulates Lipin 1 Localization to Control the SREBP Pathway
Peterson, T. R., Sengupta, S., Harris, T. E., Carmack, A. E., Kang, S. A., Balderas, E., Guertin, D. A., Madden, K. L., Carpenter, A. E., Finck, B. N., et al. (2011) · Cell · doi:10.1016/j.cell.2011.06.034 · Cited by 1,293 · cited 9×
“In the feeding state, SREBP-1c is regulated by four pathways: activated AKT stimulates liver X receptor (LXR), which is require for SREBP-1c transcription [64]; activated AKT stimulates mTORC1 to activate SREBP-1c transcription, and mTORC1 also inhibits Lipin-1, which decreases the half-life of nuclear SREBP-1c [65, 6…”
BackgroundInfluentialPRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase
Sancak, Y., Thoreen, C. C., Peterson, T. R., Lindquist, R. A., Kang, S. A., Spooner, E., Carr, S. A., & Sabatini, D. M. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.03.003 · Cited by 1,236 · cited 1×
“mTOR, a well-known phosphorylation target of AKT, specifically binds to Rheb GTPase with GTPase-activating protein (GAP) activity, which directly activates mTORC1[121].”
BackgroundHolland, W. L., Brozinick, J. T., Wang, L.-P., Hawkins, E. D., Sargent, K. M., Liu, Y., Narra, K., Hoehn, K. L., Knotts, T. A., Siesky, A., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.01.002 · Cited by 1,232 · cited 1×
“Ceramides disturb insulin signalling by AKT, leading to reduction of glucose utilization [54].”
BackgroundKulkarni, R., Brüning, J. C., Winnay, J. N., Postic, C., Magnuson, M. A., & Kahn, C. R. (1999) · Cell · doi:10.1016/s0092-8674(00)80546-2 · Cited by 1,148 · cited 1×
“β cell-specific knockout of IRS2 or the IR, which disrupts of insulin signalling in pancreatic β cells, reduces the pancreatic insulin content, β cell mass and glucose-stimulated insulin secretion, followed by the development of a phenotype similar to T2DM [140, 141].”
Glucose transporters in the 21st Century
Thorens, B., & Mueckler, M. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00712.2009 · Cited by 1,013 · cited 1×
“AKT directly phosphorylates AS160, inducing GLUT4 translocation, which translocated to the plasma membrane from storage vesicles and transports glucose in skeletal muscle following stimulation of insulin and AKT [38, 39].”
BackgroundEpidemiology of Obesity and Diabetes and Their Cardiovascular Complications
Bhupathiraju, S. N., & Hu, F. B. (2016) · Circulation Research · doi:10.1161/circresaha.115.306825 · Cited by 1,000 · cited 1×
“In the chronically obesity, the prevalence of diabetes significantly increased, which is four times higher than the general population [5].”
BackgroundSelective versus Total Insulin Resistance: A Pathogenic Paradox
Brown, M. S., & Goldstein, J. L. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.12.009 · Cited by 959
Gao, T., Furnari, F., & Newton, A. C. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.03.008 · Cited by 906 · cited 1×
“Protein phosphatase 2A (PP2A) [23] and PH domain leucine-rich repeat protein phosphatases (PHLPP1 and PHLPP2) [24] dephosphorylate AKT T308 and S473, respectively, leading to AKT inactivation.”
BackgroundVascular Complications of Diabetes: Mechanisms of Injury and Protective Factors
Rask‐Madsen, C., & King, G. L. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2012.11.012 · Cited by 884 · cited 1×
“caemia, along with various comorbidities, such as cardiovascular disease, obesity, microangiopathy and renal failure [3].”
BackgroundThe Role of Insulin Resistance in Nonalcoholic Fatty Liver Disease
Utzschneider, K. M., & Kahn, S. E. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0587 · Cited by 874 · cited 2×
“PI3K, Phosphoinositide 3-kinase; AKT, protein kinase B; T2DM, type 2 diabetes mellitus; RTKs, receptor tyrosine kinases; GPCR, G-protein-coupled receptors; PIP2, phosphatidylinositol 4,5-biphosphate; PIP3, phosphatidylinositol 3,4,5-triphosphate; PTEN, Phosphatase and tensin homologue; PDK1, phosphoinositide-dependent…”
BackgroundBugianesi, E., Gastaldelli, A., Vanni, E., Gambino, R., Cassader, M., Baldi, S., Ponti, V., Pagano, G., Ferrannini, E., & Rizzetto, M. (2005) · Diabetologia · doi:10.1007/s00125-005-1682-x · Cited by 770
Li, S., Brown, M. S., & Goldstein, J. L. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914798107 · Cited by 733 · cited 9×
“In the feeding state, SREBP-1c is regulated by four pathways: activated AKT stimulates liver X receptor (LXR), which is require for SREBP-1c transcription [64]; activated AKT stimulates mTORC1 to activate SREBP-1c transcription, and mTORC1 also inhibits Lipin-1, which decreases the half-life of nuclear SREBP-1c [65, 6…”
BackgroundInfluentialWhitman, M., Kaplan, D., Schaffhausen, B., Cantley, L., & Roberts, T. (1985) · Nature · doi:10.1038/315239a0 · Cited by 732 · cited 1×
“Phosphoinositide 3-kinase (PI3K) was discovered in 1985 and identified as a previously unknown phosphoinositide kinase [7, 8].”
BackgroundInsulin Action in AgRP-Expressing Neurons Is Required for Suppression of Hepatic Glucose Production
Könner, A. C., Janoschek, R., Plum, L., Jordan, S. D., Rother, E., Ma, X., Xu, C., Enriori, P., Hampel, B., Barsh, G. S., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.05.004 · Cited by 695 · cited 3×
“Another way to regulate HGP is PI3K-stimulated generation of PIP3 in AgRP neurons, which activates K (ATP) channels, decreasing G6PC expression in the liver [91].”
BackgroundInfluentialYecies, J. L., Zhang, H., Menon, S., Liu, S., Yecies, D. W., Lipovsky, A. I., Görgün, C. Z., Kwiatkowski, D. J., Hotamışlıgil, G. S., Lee, C., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.06.002 · Cited by 685 · cited 1×
“AKT suppresses the expression of INSIG2A, a liver-specific transcript encoding the SREBP-1c inhibitor INSIG2, through an mTORC1-independent pathway [98].”
BackgroundRole of Akt/protein kinase B in metabolism
Whiteman, E. L., Cho, H., & Birnbaum, M. J. (2002) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(02)00662-8 · Cited by 671 · cited 1×
“Most of the extracellular glucose is produced in the kidneys and liver, and only the liver acutely responds to insulin by reducing glucose levels [81].”
BackgroundBrain Insulin Resistance at the Crossroads of Metabolic and Cognitive Disorders in Humans
Kullmann, S., Heni, M., Hallschmid, M., Fritsche, A., Preissl, H. T., & Häring, H. (2016) · Physiological Reviews · doi:10.1152/physrev.00032.2015 · Cited by 654 · cited 1×
“second, brain insulin action is attenuated or even diminished in response to both endogenous and exogenous insulin stimulation [133], which impairs hypothalamic AKT activation due to ER stress and the activation of inflammatory pathways [134].”
BackgroundFOXO transcription factors: key regulators of cellular quality control
Webb, A. E., & Brunet, A. (2014) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2014.02.003 · Cited by 649 · cited 1×
“On the other hand, FoxO1 induces the expression of phosphoenolpyruvate carboxykinase (PEPCK) and glucose-6-phosphatase gene (G6PC), subsequently increases gluconeogenesis [33].”
BackgroundAdipocyte Turnover: Relevance to Human Adipose Tissue Morphology
Arner, E., Westermark, P. O., Spalding, K. L., Britton, T., Rydén, M., Frisén, J., Bernard, S., & Arner, P. (2010) · Diabetes · doi:10.2337/db09-0942 · Cited by 645
Hypothalamic KATP channels control hepatic glucose production
Pocai, A., Lam, T. K. T., Gutierrez-Juarez, R., Obici, S., Schwartz, G. J., Bryan, J., Aguilar-Bryan, L., & Rossetti, L. (2005) · Nature · doi:10.1038/nature03439 · Cited by 645 · cited 1×
“First, insulin action in the hypothalamus through K (ATP) channels decrease expression of G6PC and hepatic glucose production (HGP) in liver [89, 90].”
BackgroundAlessi, D. R., Barry Caudwell, F., Andjelkovic, M., Hemmings, B. A., & Cohen, P. (1996) · FEBS Letters · doi:10.1016/s0014-5793(96)01370-1 · Cited by 628 · cited 1×
“Those effectors share a common minimal sequence motif, Arg-Xaa-Arg-Yaa-Zaa-Ser-Hyd [28].”
BackgroundTranscriptional Control of Adipose Lipid Handling by IRF4
Eguchi, J., Wang, X., Yu, S., Kershaw, E. E., Chiu, P. C., Dushay, J. R., Estall, J. L., Klein, U., Maratos–Flier, E., & Rosen, E. D. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.02.005 · Cited by 597 · cited 5×
“PI3K, Phosphoinositide 3-kinase; AKT, protein kinase B; T2DM, type 2 diabetes mellitus; RTKs, receptor tyrosine kinases; GPCR, G-protein-coupled receptors; PIP2, phosphatidylinositol 4,5-biphosphate; PIP3, phosphatidylinositol 3,4,5-triphosphate; PTEN, Phosphatase and tensin homologue; PDK1, phosphoinositide-dependent…”
BackgroundInfluentialThe cell biology of fat expansion
Rutkowski, J. M., Stern, J. H., & Scherer, P. E. (2015) · Journal of Cell Biology · doi:10.1083/jcb.201409063 · Cited by 541 · cited 1×
“In the presence of adipose hypertrophy, insulin resistance also occurs because of the expansion of adipose tissues exceeds their storage capacity [45, 78, 79].”
BackgroundKubota, N., Tobe, K., Terauchi, Y., Eto, K., Yamauchi, T., Suzuki, R., Tsubamoto, Y., Komeda, K., Nakano, R., Miki, H., et al. (2000) · Diabetes · doi:10.2337/diabetes.49.11.1880 · Cited by 519 · cited 1×
“However, insulin has consistently been shown to play an important role in pancreatic cells [139], mainly through PI3K/AKT”
Backgroundβ cell replication is the primary mechanism for maintaining postnatal β cell mass
Georgia, S. K., & Bhushan, A. (2004) · Journal of Clinical Investigation · doi:10.1172/jci22098 · Cited by 510 · cited 1×
“Activation of the PI3K/AKT pathway promotes insulin secretion form pancreatic β cells [142, 143].”
BackgroundDiacylglycerol-mediated insulin resistance
Erion, D. M., & Shulman, G. I. (2010) · Nature Medicine · doi:10.1038/nm0410-400 · Cited by 502 · cited 4×
“Excessive lipid production and impaired disposal may promote the development of insulin resistance and diabetes in the skeletal muscle [47, 48].”
BackgroundInfluentialAndjelković, M., Jakubowicz, T., Cron, P. D., Ming, X., Han, J. W., & Hemmings, B. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.5699 · Cited by 497 · cited 2×
“PI3K, Phosphoinositide 3-kinase; AKT, protein kinase B; T2DM, type 2 diabetes mellitus; RTKs, receptor tyrosine kinases; GPCR, G-protein-coupled receptors; PIP2, phosphatidylinositol 4,5-biphosphate; PIP3, phosphatidylinositol 3,4,5-triphosphate; PTEN, Phosphatase and tensin homologue; PDK1, phosphoinositide-dependent…”
BackgroundAkt/PKB regulates hepatic metabolism by directly inhibiting PGC-1α transcription coactivator
Li, X., Monks, B., Ge, Q., & Birnbaum, M. J. (2007) · Nature · doi:10.1038/nature05861 · Cited by 487 · cited 1×
“FoxO1 and peroxisome proliferator-activated receptor-coactivator 1α (PGC1α) coordinately regulate gene expression to increase gluconeogenesis and fatty acid oxidation [32].”
BackgroundDong, X. C., Copps, K. D., Guo, S., Li, Y., Kollipara, R., DePinho, R. A., & White, M. F. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.06.006 · Cited by 463 · cited 1×
“In previous studies, insulin suppressed PEPCK and G6PC expression, which are known to increase hepatic gluconeogenesis by activating the PI3K/AKT pathway [84-86].”
BackgroundPorstmann, T., Griffiths, B. L., Chung, Y., Delpuech, O., Griffiths, J. R., Downward, J., & Schulze, A. (2005) · Oncogene · doi:10.1038/sj.onc.1208802 · Cited by 463
Forkhead protein FoxO1 mediates Agrp-dependent effects of leptin on food intake
Kitamura, T., Feng, Y., Kitamura, Y., Chua, S. C., Xu, A. W., Barsh, G. S., Rossetti, L., & Accili, D. (2006) · Nature Medicine · doi:10.1038/nm1392 · Cited by 458 · cited 1×
“In a subsequent study, leptin and insulin were shown to coordinately regulate FoxO1 activity, increasing the expression of NPY and AgRP and suppressing POMC expression [115, 116].”
BackgroundUnraveling the Regulation of Hepatic Metabolism by Insulin
Titchenell, P. M., Lazar, M. A., & Birnbaum, M. J. (2017) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2017.03.003 · Cited by 457 · cited 1×
“Three pathways may mediate cell-nonautonomous effects on hepatic glucose metabolism [88].”
BackgroundThe critical role of Akt in cardiovascular function
Abeyrathna, P., & Su, Y. (2015) · Vascular Pharmacology · doi:10.1016/j.vph.2015.05.008 · Cited by 439 · cited 3×
“AKT1 expresses ubiquitously, AKT2 mainly expresses in insulin-sensitive tissues, such as skeletal muscle, adipose tissues and liver, and AKT3 expresses in the testes and brain [9, 18].”
BackgroundVarela, L., & Horvath, T. L. (2012) · The EMBO Reports · doi:10.1038/embor.2012.174 · Cited by 426 · cited 1×
“In the hypothalamic arcuate nucleus (ARC), anorexigenic proopiomelanocortin (POMC) and orexigenic AgRP coordinately regulate food intake and energy expenditure, as well as peripheral tissue glucose homeostasis and energy partitioning through insulin, leptin and nutrients [111].”
BackgroundDose-response curves for in vivo insulin sensitivity in individual tissues in rats
Kraegen, E. W., James, D. E., Jenkins, A. B., & Chisholm, D. J. (1985) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1985.248.3.e353 · Cited by 409 · cited 1×
“Approximately 90% of insulin-stimulated glucose utilization occurs in skeletal muscle and plays an important role in regulating glucose metabolism and energy homeostasis [36].”
BackgroundSchenk, S., & Horowitz, J. F. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30566 · Cited by 407 · cited 3×
“In early studies, insulin resistance was thought to be accompanied by excessive intramyocellular lipid (IMCL) levels [49], and improved insulin sensitivity observed in subjects with T2DM by reduced IMCL levels [50].”
BackgroundInsulin resistance and impaired adipogenesis
Gustafson, B., Hedjazifar, S., Gogg, S., Hammarstedt, A., & Smith, U. (2015) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2015.01.006 · Cited by 407 · cited 2×
“In the presence of adipose hypertrophy, insulin resistance also occurs because of the expansion of adipose tissues exceeds their storage capacity [45, 78, 79].”
BackgroundPtdIns(3,4,5) P 3-Dependent Activation of the mTORC2 Kinase Complex
Liu, P., Gan, W., Chin, Y. R., Ogura, K., Guo, J., Zhang, J., Wang, B., Blenis, J., Cantley, L. C., Toker, A., et al. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0460 · Cited by 403 · cited 1×
“First, phosphorylation of the threonine 308 (AKT1) in the kinase domain by phosphoinositide-dependent protein kinase 1 (PDK1) initiates the activation process [19], subsequent phosphorylation at serine 473 (AKT1) in the carboxy-terminal regulatory domain through mTOR complex 2 (mTORC2)[17, 20], which is activated by a…”
BackgroundSelf-citationCentral nervous system control of metabolism
Myers, M. G., & Olson, D. P. (2012) · Nature · doi:10.1038/nature11705 · Cited by 399 · cited 2×
“In the presence of persistent excess energy availability, leptin signalling activates other pathways, such as STAT3 or SH2-containing tyrosine phosphatase, to predominantly regulate food intake in POMC neurons [90, 113, 119].”
BackgroundInsulin regulates liver metabolism in vivo in the absence of hepatic Akt and Foxo1
Lu, M., Wan, M., Leavens, K. F., Chu, Q., Monks, B. R., Fernandez, S., Ahima, R. S., Ueki, K., Kahn, C. R., & Birnbaum, M. J. (2012) · Nature Medicine · doi:10.1038/nm.2686 · Cited by 392 · cited 3×
“Additionally, those mice still maintained the normal postprandial state, even in the absence of canonical liver insulin signalling [85, 87].”
BackgroundResultHill, J. W., Elias, C. F., Fukuda, M., Williams, K. W., Berglund, E. D., Holland, W. L., Cho, Y.-R., Chuang, J.-C., Xu, Y., Choi, M., et al. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.03.002 · Cited by 391 · cited 1×
“The selective inactivation of IR in AgRP neurons in mice results in an inability to suppress HGP whereas only a deficiency in both leptin and IRs in POMC neurons resulted in systemic insulin resistance [45, 129].”
BackgroundThe PI3K/AKT Pathway and Renal Cell Carcinoma
Guo, H., Germán, P., Bai, S., Barnes, S., Guo, W., Qi, X., Lou, H., Liang, J., Jonasch, E. W., Mills, G. B., et al. (2015) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2015.03.003 · Cited by 383 · cited 2×
“Phosphoinositide 3-kinase (PI3K) was discovered in 1985 and identified as a previously unknown phosphoinositide kinase [7, 8].”
BackgroundLiu, T., Shi, C., Gao, R., Sun, H., Xiong, X., Ding, L., Chen, Q., Li, Y., Wang, J., Kang, Y., et al. (2015) · Clinical Science · doi:10.1042/cs20150009 · Cited by 378
The Akt–SREBP nexus: cell signaling meets lipid metabolism
Krycer, J. R., Sharpe, L. J., Luu, W., & Brown, A. J. (2010) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2010.01.001 · Cited by 370 · cited 4×
“AKT regulates lipid metabolism through sterol regulatory element-binding proteins (SREBP), which increases cholesterol and fatty acid accumulation, including SREBP-1c, SREBP-1a, and SREBP-2[18, 34].”
BackgroundInfluentialAcute effects of leptin require PI3K signaling in hypothalamic proopiomelanocortin neurons in mice
Hill, J. W., Williams, K. W., Ye, C., Luo, J., Balthasar, N., Coppari, R., Cowley, M. A., Cantley, L. C., Lowell, B. B., & Elmquist, J. K. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32964 · Cited by 362 · cited 2×
“In the presence of persistent excess energy availability, leptin signalling activates other pathways, such as STAT3 or SH2-containing tyrosine phosphatase, to predominantly regulate food intake in POMC neurons [90, 113, 119].”
BackgroundUeki, K., Yamamoto‐Honda, R., Kaburagi, Y., Yamauchi, T., Tobe, K., Burgering, B. M. T., Coffer, P. J., Komuro, I., Akanuma, Y., Yazaki, Y., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.9.5315 · Cited by 357
Benoit, S. C., Kemp, C. J., Elias, C. F., Abplanalp, W., Herman, J. P., Migrenne, S., Lefevre, A.-L., Cruciani-Guglielmacci, C., Magnan, C., Yu, F., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci36714 · Cited by 351 · cited 1×
“Insulin signalling is blocked during insulin resistance in the brain due to increased protein kinase C (PKC) activity, ER stress and inflammation [134, 135], which blocks the ability of PI3K to generate PIP3.”
BackgroundSchmoll, D., Walker, K. S., Alessi, D. R., Grempler, R., Burchell, A., Guo, S., Walther, R., & Unterman, T. G. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003616200 · Cited by 349 · cited 1×
“In previous studies, insulin suppressed PEPCK and G6PC expression, which are known to increase hepatic gluconeogenesis by activating the PI3K/AKT pathway [84-86].”
BackgroundHypothalamic nutrient sensing in the control of energy homeostasis
Blouet, C., & Schwartz, G. J. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.12.024 · Cited by 343 · cited 1×
“However, mTOR1 signalling is required for glucose homeostasis in the hypothalamus [126, 127].”
BackgroundKahn, S. E., Prigeon, R. L., McCulloch, D. K., Boyko, E. J., Bergman, R. N., Schwartz, M. W., Neifing, J. L., Ward, W. K., Beard, J. C., Palmer, J. P., et al. (1993) · Diabetes · doi:10.2337/diabetes.42.11.1663 · Cited by 328
PI3K/Akt signaling in osteosarcoma
Zhang, J., Yu, X., Yan, Y., Wang, C., & Wang, W. (2015) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.12.041 · Cited by 328 · cited 6×
“First, phosphorylation of the threonine 308 (AKT1) in the kinase domain by phosphoinositide-dependent protein kinase 1 (PDK1) initiates the activation process [19], subsequent phosphorylation at serine 473 (AKT1) in the carboxy-terminal regulatory domain through mTOR complex 2 (mTORC2)[17, 20], which is activated by a…”
BackgroundInfluentialInterplay between FOXO, TOR, and Akt
Hay, N. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.03.013 · Cited by 327 · cited 3×
“AKT regulates lipid metabolism through sterol regulatory element-binding proteins (SREBP), which increases cholesterol and fatty acid accumulation, including SREBP-1c, SREBP-1a, and SREBP-2[18, 34].”
BackgroundEnzymatic Reduction of Oxysterols Impairs LXR Signaling in Cultured Cells and the Livers of Mice
Chen, W., Chen, G., Head, D. L., Mangelsdorf, D. J., & Russell, D. W. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2006.11.012 · Cited by 325 · cited 1×
“In the feeding state, SREBP-1c is regulated by four pathways: activated AKT stimulates liver X receptor (LXR), which is require for SREBP-1c transcription [64]; activated AKT stimulates mTORC1 to activate SREBP-1c transcription, and mTORC1 also inhibits Lipin-1, which decreases the half-life of nuclear SREBP-1c [65, 6…”
BackgroundLeptin signalling pathways in hypothalamic neurons
Kwon, O., Kim, K. W., & Kim, M. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2133-1 · Cited by 306 · cited 1×
“Leptin is the most important hormone reported to date that regulates food intake and energy balance [110].”
BackgroundInsulin stimulation of SREBP-1c processing in transgenic rat hepatocytes requires p70 S6-kinase
Owen, J. L., Zhang, Y., Bae, S., Farooqi, M. S., Liang, G., Hammer, R. E., Goldstein, J. L., & Brown, M. S. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1213343109 · Cited by 305 · cited 1×
“In the feeding state, SREBP-1c is regulated by four pathways: activated AKT stimulates liver X receptor (LXR), which is require for SREBP-1c transcription [64]; activated AKT stimulates mTORC1 to activate SREBP-1c transcription, and mTORC1 also inhibits Lipin-1, which decreases the half-life of nuclear SREBP-1c [65, 6…”
BackgroundTitchenell, P. M., Quinn, W. J., Lu, M., Chu, Q., Lu, W., Li, C., Chen, H., Monks, B. R., Chen, J., Rabinowitz, J. D., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.04.022 · Cited by 298
Maintenance of metabolic homeostasis by Sestrin2 and Sestrin3
Lee, J. H., Budanov, A. V., Talukdar, S., Park, E. J., Park, H. L., Park, H.-W., Bandyopadhyay, G., Li, N., Aghajan, M., Jang, I., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.08.004 · Cited by 295 · cited 1×
“MCF7-tet OFF Sesn2F cells Sestrins (Sesn1/2/3) through activation of AMPK and mTORC2, which is necessary for activation of AKT Regulate both glucose and lipid metabolism [164, 165]”
BackgroundAgRP Neurons Control Systemic Insulin Sensitivity via Myostatin Expression in Brown Adipose Tissue
Steculorum, S. M., Ruud, J., Karakasilioti, I., Backes, H., Engström, L., Timper, K., Hess, M. E., Tsaousidou, E., Mauer, J., Vogt, M. C., et al. (2016) · Cell · doi:10.1016/j.cell.2016.02.044 · Cited by 293
Brain Insulin Controls Adipose Tissue Lipolysis and Lipogenesis
Scherer, T., O’Hare, J., Diggs‐Andrews, K. A., Schweiger, M., Cheng, B., Lindtner, C., Zieliński, E., Vempati, P., Su, K., Dighe, S. V., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.01.008 · Cited by 270
Anitha, M. (2006) · Journal of Clinical Investigation · doi:10.1172/jci26295 · Cited by 263 · cited 1×
“Pancreatic beta-cell glial cell line-derived neurotrophic factor (GDNF) Activates phosphorylation of AKT improves glucose tolerance and β cell mass [157, 158]”
BackgroundFoxO1, the transcriptional chief of staff of energy metabolism
Kousteni, S. (2011) · Bone · doi:10.1016/j.bone.2011.06.034 · Cited by 248 · cited 2×
“AKT directly inhibits FoxO1, reducing glucose levels [31], FoxO1”
BackgroundKubota, N., Kubota, T., Itoh, S., Kumagai, H., Kozono, H., Takamoto, I., Mineyama, T., Ogata, H., Tokuyama, K., Ohsugi, M., et al. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.05.007 · Cited by 244 · cited 1×
“increases glycogen synthesis and the synthesis of fatty acids for storage and subsequent utilization by other tissues [82, 83].”
BackgroundSkeletal muscle mitochondria as a target to prevent or treat type 2 diabetes mellitus
Hesselink, M. K. C., Schrauwen-Hinderling, V., & Schrauwen, P. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.104 · Cited by 242 · cited 1×
“Excessive fatty acid oxidation in the mitochondria via the tricarboxylic acid (TCA) cycle and the electron transport chain (ETC) increases the production of fatty acid metabolites and reactive oxygen species (ROS), subsequently activated intracellular stress kinases to inhibit IRS-1 and possibly exerting effects on in…”
BackgroundS-Nitrosylation links obesity-associated inflammation to endoplasmic reticulum dysfunction
Yang, L., Calay, E. S., Fan, J., Arduini, A., Kunz, R. C., Gygi, S. P., Yalçın, A., Fu, S., & Hotamışlıgil, G. S. (2015) · Science · doi:10.1126/science.aaa0079 · Cited by 235 · cited 1×
“Chronic metabolic inflammation and endoplasmic reticulum (ER) stress also impair hepatic insulin-AKT signalling and subsequently causes insulin resistance [106, 107].”
BackgroundChakrabarti, P., & Kandror, K. V. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.c800241200 · Cited by 233 · cited 4×
“The substrate SREBP, which regulates fatty acid synthase and cholesterol-related genes [18, 61], and FOXO1, which regulates lipolysis by controlling the expression of adipose triglyceride lipase (ATGL) [62], are primary substrates for AKT-mediated lipid metabolism [63].”
BackgroundInfluentialPI3K‐independent AKT activation in cancers: A treasure trove for novel therapeutics
Mahajan, K. N., & Mahajan, N. P. (2012) · Journal of Cellular Physiology · doi:10.1002/jcp.24065 · Cited by 229 · cited 1×
“Although several studies have reported an absolute requirement for PI3K in AKT activation, AKT activation has also been suggested to be mediated by a PI3K-independent mechanism [27].”
BackgroundMorrison, C. D., Morton, G. J., Niswender, K. D., Gelling, R. W., & Schwartz, M. W. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00094.2005 · Cited by 228 · cited 1×
“Leptin requires intact PI3K signalling to promote hypothalamic expression of POMC genes and inhibit expression of the NPY and AgRP genes [113, 114].”
BackgroundBernal‐Mizrachi, E., Fátrai, S., Johnson, J. D., Ohsugi, M., Otani, K., Han, Z., Polonsky, K. S., & Permutt, M. A. (2004) · Journal of Clinical Investigation · doi:10.1172/jci20016 · Cited by 223 · cited 1×
“In contrast, overexpression of a kinase dead mutant in β cells, which reduced AKT activity by 80%, results in a lack of insulin secretion [145].”
BackgroundInsulin Regulates Adipocyte Lipolysis via an Akt-Independent Signaling Pathway
Choi, S. M., Tucker, D. F., Gross, D. N., Easton, R., DiPilato, L. M., Dean, A. S., Monks, B. R., & Birnbaum, M. J. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00797-10 · Cited by 223 · cited 5×
“In the fed state, PI3K/AKT inhibits protein kinase A (PKA) and thus suppresses lipolysis.”
BackgroundInfluentialFrom chronic overnutrition to insulin resistance: The role of fat-storing capacity and inflammation
Lionetti, L., Mollica, M. P., Lombardi, A., Cavaliere, G., Gifuni, G., & Barletta, A. (2009) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2008.10.010 · Cited by 223 · cited 1×
“However, this process triggers the ectopic accumulation of lipids and subsequently causes lipotoxicity and insulin resistance [75].”
BackgroundChREBP, but not LXRs, is required for the induction of glucose-regulated genes in mouse liver
Denechaud, P., Bossard, P., Lobaccaro, J. A., Millatt, L. J., Staels, B., Girard, J. R., & Postic, C. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34314 · Cited by 223 · cited 1×
“In normal physiology, feeding is able to activate synthesis of SREBP-1c via insulin-dependent pathway (mTORC1) or insulin-independent pathway (carbohydrate response element binding protein (ChREBP)) [59, 60].”
BackgroundPeng, M., Yin, N., & Li, M. O. (2014) · Cell · doi:10.1016/j.cell.2014.08.038 · Cited by 220 · cited 1×
“MCF7-tet OFF Sesn2F cells Sestrins (Sesn1/2/3) through activation of AMPK and mTORC2, which is necessary for activation of AKT Regulate both glucose and lipid metabolism [164, 165]”
BackgroundHaas, J. T., Miao, J., Chanda, D., Wang, Y., Zhao, E., Haas, M. E., Hirschey, M. D., Vaitheesvaran, B., Farese, R. V., Kurland, I. J., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.05.002 · Cited by 216 · cited 2×
“In normal physiology, feeding is able to activate synthesis of SREBP-1c via insulin-dependent pathway (mTORC1) or insulin-independent pathway (carbohydrate response element binding protein (ChREBP)) [59, 60].”
BackgroundSynergy in activating class I PI3Ks
Burke, J. E., & Williams, R. L. (2015) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2014.12.003 · Cited by 216 · cited 1×
“RTKs recruit class I PI3Ks to the plasma membrane, which relieves the inactivation function of p85 and p110 to activate the protein [12, 13].”
BackgroundFree fatty acids and skeletal muscle insulin resistance
Kraegen, E. W., & Cooney, G. J. (2008) · Current Opinion in Lipidology · doi:10.1097/01.mol.0000319118.44995.9a · Cited by 210 · cited 3×
“Excessive fatty acid oxidation in the mitochondria via the tricarboxylic acid (TCA) cycle and the electron transport chain (ETC) increases the production of fatty acid metabolites and reactive oxygen species (ROS), subsequently activated intracellular stress kinases to inhibit IRS-1 and possibly exerting effects on in…”
BackgroundRapid Activation of Akt2 Is Sufficient to Stimulate GLUT4 Translocation in 3T3-L1 Adipocytes
Ng, Y., Ramm, G., Lopez, J. A., & James, D. E. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.02.008 · Cited by 203 · cited 1×
“Previous research has found knockout or knockdown of AKT or IRS adaptor proteins obviously reduce insulin-induced glucose uptake, whereas overexpression of AKT increases glucose uptake [37].”
BackgroundFoxO1 Target Gpr17 Activates AgRP Neurons to Regulate Food Intake
Ren, H., Orozco, I. J., Su, Y., Suyama, S., Juárez, R. G., Horváth, T. L., Wardlaw, S. L., Plum, L., Arancio, O., & Accili, D. (2012) · Cell · doi:10.1016/j.cell.2012.04.032 · Cited by 201 · cited 1×
“Recently, Gpr17, the target of FoxO1, was shown to regulate feeding and sensitivity through insulin and leptin in AgRP neurons [117, 118].”
BackgroundDalamaga, Μ., Chou, S. H.-H., Shields, K. S., Papageorgiou, P., Pοlyzos, S. A., & Mantzoros, C. S. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.05.010 · Cited by 199 · cited 1×
“As shown in a previous study, acute activation of mTOR1 promotes the ability of hypothalamic neural circuits to sense the nutritional milieu and regulate feeding [122, 123].”
BackgroundCombating the dual burden: therapeutic targeting of common pathways in obesity and type 2 diabetes
Scheen, A. J., & Gaal, L. F. V. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70004-x · Cited by 193 · cited 1×
“Both obesity and T2DM are associated with insulin resistance [6].”
BackgroundHaeusler, R. A., Hartil, K., Vaitheesvaran, B., Arrieta‐Cruz, I., Knight, C. M., Cook, J. R., Kammoun, H. L., Febbraio, M. A., Juárez, R. G., Kurland, I. J., et al. (2014) · Nature Communications · doi:10.1038/ncomms6190 · Cited by 192 · cited 1×
“The role of FoxO1 in liver lipid metabolism is less well studied; some studies have shown that FoxO1 is directly associated with insulin-promoted expression of fat genes in the liver, whereas others have reported a permissive role for FoxO1 in these processes [100-102].”
BackgroundPTEN Regulates PI(3,4)P2 Signaling Downstream of Class I PI3K
Malek, M., Kielkowska, A., Chessa, T., Anderson, K. E., Barneda, D., Pir, P., Nakanishi, H., Eguchi, S., Koizumi, A., Sasaki, J., et al. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.09.024 · Cited by 190
Critical Role for Hypothalamic mTOR Activity in Energy Balance
Mori, H., Inoki, K., Münzberg, H., Opland, D. M., Faouzi, M., Villanueva, E. C., Ikenoue, T., Kwiatkowski, D. J., MacDougald, O. A., Myers, M. G., et al. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.03.005 · Cited by 188 · cited 1×
“As shown in a previous study, acute activation of mTOR1 promotes the ability of hypothalamic neural circuits to sense the nutritional milieu and regulate feeding [122, 123].”
BackgroundActivation of hypothalamic S6 kinase mediates diet-induced hepatic insulin resistance in rats
Ono, H., Pocai, A., Wang, Y., Sakoda, H., Asano, T., Backer, J., Schwartz, G. J., & Rossetti, L. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34277 · Cited by 183
Selective impairment of insulin signalling in the hypothalamus of obese Zucker rats
Carvalheira, J. B. C., Ribeiro, E. B., Ara�jo, E. P., Guimar�es, R. B., Telles, M. M., Torsoni, M., Gontijo, J. A. R., Velloso, L. A., & Saad, M. J. A. (2003) · Diabetologia · doi:10.1007/s00125-003-1246-x · Cited by 176 · cited 1×
“Leptin and insulin-mediate PI3K/AKT signalling is impaired in the brains of obese subjects with insulin resistance [132].”
BackgroundKubota, T., Kubota, N., & Kadowaki, T. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.03.004 · Cited by 174 · cited 1×
“including protecting tissues and organs from cold and hot, thermogenesis and the production of various hormones/cytokines that are collectively referred to as cytokines [56, 57].”
BackgroundBraccini, L., Ciraolo, E., Campa, C., Perino, A., Longo, D., Tibolla, G., Pregnolato, M., Cao, Y., Tassone, B., Damilano, F., et al. (2015) · Nature Communications · doi:10.1038/ncomms8400 · Cited by 171 · cited 1×
“Recently, endomembranes that contain PIP3 and PIP2 have also been shown to directly contribute to AKT activation [25, 26].”
BackgroundHepatic insulin signalling is dispensable for suppression of glucose output by insulin in vivo
Titchenell, P. M., Chu, Q., Monks, B. R., & Birnbaum, M. J. (2015) · Nature Communications · doi:10.1038/ncomms8078 · Cited by 169 · cited 3×
“Additionally, those mice still maintained the normal postprandial state, even in the absence of canonical liver insulin signalling [85, 87].”
BackgroundResultThe Role of Mitochondria in the Pathophysiology of Skeletal Muscle Insulin Resistance
Pagel-Langenickel, I., Bao, J., Pang, L., & Sack, M. N. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0003 · Cited by 154 · cited 1×
“Excessive lipid production and impaired disposal may promote the development of insulin resistance and diabetes in the skeletal muscle [47, 48].”
BackgroundHigh-fat diet, muscular lipotoxicity and insulin resistance
Schrauwen, P. (2007) · Proceedings of the Nutrition Society · doi:10.1017/s0029665107005277 · Cited by 153 · cited 1×
“In early studies, insulin resistance was thought to be accompanied by excessive intramyocellular lipid (IMCL) levels [49], and improved insulin sensitivity observed in subjects with T2DM by reduced IMCL levels [50].”
BackgroundDeng, X., Zhang, W., O‐Sullivan, I., Williams, J. B., Dong, Q., Park, E. A., Raghow, R., Unterman, T. G., & Elam, M. B. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.347211 · Cited by 150 · cited 1×
“The role of FoxO1 in liver lipid metabolism is less well studied; some studies have shown that FoxO1 is directly associated with insulin-promoted expression of fat genes in the liver, whereas others have reported a permissive role for FoxO1 in these processes [100-102].”
BackgroundLipid Mediators of Insulin Resistance
Holland, W. L., Knotts, T. A., Chavez, J. A., Wang, L.-P., Hoehn, K. L., & Summers, S. A. (2008) · Nutrition Reviews · doi:10.1111/j.1753-4887.2007.tb00327.x · Cited by 149 · cited 1×
“In the presence of insulin resistance, the level of free fatty acids increases in the body resulting in the accumulation of intramyocellular lipids, such as DAG and ceramides [52].”
BackgroundA Phosphorylation Cascade Controls the Degradation of Active SREBP1
Bengoechea-Alonso, M. T., & Ericsson, J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m807906200 · Cited by 149 · cited 9×
“In the feeding state, SREBP-1c is regulated by four pathways: activated AKT stimulates liver X receptor (LXR), which is require for SREBP-1c transcription [64]; activated AKT stimulates mTORC1 to activate SREBP-1c transcription, and mTORC1 also inhibits Lipin-1, which decreases the half-life of nuclear SREBP-1c [65, 6…”
BackgroundInfluentialKubota, N., Kubota, T., Kajiwara, E., Iwamura, T., Kumagai, H., Watanabe, T., Inoue, M., Takamoto, I., Sasako, T., Kumagai, K., et al. (2016) · Nature Communications · doi:10.1038/ncomms12977 · Cited by 143 · cited 1×
“And recent study finds Irs2-knockout mice develop ‘selective insulin resistance’, whereas mice lacking in Irs1, or both Irs1 and Irs2, develop ‘total insulin resistance’, which indicates the IRS 1/2 are the cause of insulin selective resistance [109]; in the second, hepatic insulin signalling remains intact but the ce…”
BackgroundWan, M., Leavens, K. F., Saleh, D., Easton, R., Guertin, D. A., Peterson, T. R., Kaestner, K. H., Sabatini, D. M., & Birnbaum, M. J. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.09.001 · Cited by 140 · cited 1×
“However, in the absence of AKT2, the activation of mTORC1 and SREBP-1c is not sufficient to drive postprandial lipid generation [99].”
BackgroundTargeting glycogen synthase kinase-3 (GSK-3) in the treatment of Type 2 diabetes
MacAulay, K., & Woodgett, J. R. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.10.1265 · Cited by 140
FOXO1 in the ventromedial hypothalamus regulates energy balance
Kim, K. W., Donato, J., Berglund, E. D., Choi, Y., Kohno, D., Elias, C. F., DePinho, R. A., & Elmquist, J. K. (2012) · Journal of Clinical Investigation · doi:10.1172/jci62848 · Cited by 137 · cited 1×
“In a subsequent study, leptin and insulin were shown to coordinately regulate FoxO1 activity, increasing the expression of NPY and AgRP and suppressing POMC expression [115, 116].”
BackgroundPHLPP-1 Negatively Regulates Akt Activity and Survival in the Heart
Miyamoto, S., Purcell, N. H., Smith, J. M., Gao, T., Whittaker, R., Huang, K., Castillo, R., Glembotski, C. C., Sussman, M. A., Newton, A. C., et al. (2010) · Circulation Research · doi:10.1161/circresaha.109.215020 · Cited by 127
Qu, X.-Q., Seale, J., & Donnelly, R. (1999) · Journal of Endocrinology · doi:10.1677/joe.0.1620207 · Cited by 123 · cited 1×
“Meanwhile, excessive oxidation of FFAs increases the hepatic acetyl-CoA content and thus activates pyruvate carboxylase, which is required for gluconeogenesis [45], and increases DAG levels, which impair PI3K/AKT pathway and exacerbate insulin resistance [48, 105].”
BackgroundOsorio‐Fuentealba, C., Contreras‐Ferrat, A. E., Altamirano, F. J., Espinosa, A., Li, Q., Niu, W., Lavandero, S., Klip, A., & Jaimovich, E. (2012) · Diabetes · doi:10.2337/db12-1066 · Cited by 121 · cited 1×
“AKT directly phosphorylates AS160, inducing GLUT4 translocation, which translocated to the plasma membrane from storage vesicles and transports glucose in skeletal muscle following stimulation of insulin and AKT [38, 39].”
BackgroundRegulation of angiogenesis by PI3K signaling networks
Graupera, M., & Potente, M. (2013) · Experimental Cell Research · doi:10.1016/j.yexcr.2013.02.021 · Cited by 116 · cited 1×
“Class I PI3K is a heterodimer and is divided into class IA and class IB, according to differences in the molecular structure [11].”
BackgroundFAM3A Activates PI3K p110α/Akt Signaling to Ameliorate Hepatic Gluconeogenesis and Lipogenesis
Wang, C., Chi, Y., Li, J., Miao, Y., Li, S., Su, W., Shi, J., Chen, Z., Du, S., Zhang, X., et al. (2013) · Hepatology · doi:10.1002/hep.26945 · Cited by 116
Influence of mTOR in energy and metabolic homeostasis
Haissaguerre, M., Saucisse, N., & Cota, D. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.07.015 · Cited by 116 · cited 1×
“However, mTOR1 signalling is required for glucose homeostasis in the hypothalamus [126, 127].”
BackgroundEmerging evidence of signalling roles for PI(3,4)P2 in Class I and II PI3K-regulated pathways
Hawkins, P. T., & Stephens, L. (2016) · Biochemical Society Transactions · doi:10.1042/bst20150248 · Cited by 110 · cited 1×
“PIP2 is synthesized by class II PI3Ks using PIP as substrate [16].”
MethodCentral GLP-2 Enhances Hepatic Insulin Sensitivity via Activating PI3K Signaling in POMC Neurons
Shi, X., Zhou, F., Li, X., Chang, B. H.-J., Li, D., Wang, Y., Tong, Q., Xu, Y., Fukuda, M., Zhao, J. J., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.06.014 · Cited by 106 · cited 1×
“Recently, Another ligand, glucagon-like peptide (GLP-2), it was recently shown to play a key role in the control of HGP through the PI3K/AKT pathway[131], suggesting that in addition to insulin and leptin, GLP-2 also regulates HGP through PI3K/AKT signalling.”
BackgroundTissue‐specific insulin signaling in the regulation of metabolism and aging
Zhang, J., & Liu, F. (2014) · IUBMB Life · doi:10.1002/iub.1293 · Cited by 105 · cited 3×
“The pancreas is mainly composed of four types of cells, of which pancreatic β cells are vitally important in maintaining glucose homeostasis by producing and secreting insulin in response to the blood glucose concentration [58].”
BackgroundInfluentialYang, W., Wang, J., Chen, Z., Chen, J., Meng, Y., Chen, L., Chang, Y., Geng, B., Sun, L., Dou, L., et al. (2017) · Diabetes · doi:10.2337/db16-1172 · Cited by 101
Hypothalamic Insulin Resistance in Obesity: Effects on Glucose Homeostasis
Chen, W., Balland, É., & Cowley, M. A. (2017) · Neuroendocrinology · doi:10.1159/000455865 · Cited by 101 · cited 5×
“There are two reasons for this: first, the transport of insulin through the blood brain barrier is impaired in obese subjects [45].”
BackgroundInfluentialOrtega-Molina, A., Lopez-Guadamillas, E., Mattison, J. A., Mitchell, S. J., Muñoz‐Martín, M., Iglesias, G., Gutierrez, V. M., Vaughan, K. L., Szarowicz, M. D., González‐García, I., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.02.017 · Cited by 99 · cited 1×
“At this point, the pharmacological inhibition of PI3K is an effective and safe anti-obesity and anti-cancer intervention that can reverse the negative effects of human diseases [152].”
BackgroundInfluence of Insulin in the Ventromedial Hypothalamus on Pancreatic Glucagon Secretion In Vivo
Paranjape, S., Chan, O. T. M., Zhu, W., Horblitt, A. M., McNay, E. C., Cresswell, J. A., Bogan, J. S., McCrimmon, R. J., & Sherwin, R. S. (2010) · Diabetes · doi:10.2337/db10-0014 · Cited by 98
Ramnanan, C. J., Saraswathi, V., Smith, M. S., Donahue, E. P., Farmer, B., Farmer, T. D., Neal, D. W., Williams, P. E., Lautz, M., Mari, A., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45472 · Cited by 96 · cited 1×
“However, further studies should be carried on because the action of insulin in brain may not common in all species [92, 93].”
BackgroundMitochondrial dysfunction and type 2 diabetes
Parish, R., & Petersen, K. F. (2005) · Current Diabetes Reports · doi:10.1007/s11892-005-0006-3 · Cited by 84 · cited 4×
“Excessive fatty acid oxidation in the mitochondria via the tricarboxylic acid (TCA) cycle and the electron transport chain (ETC) increases the production of fatty acid metabolites and reactive oxygen species (ROS), subsequently activated intracellular stress kinases to inhibit IRS-1 and possibly exerting effects on in…”
BackgroundInfluentialRole of S6K1 in regulation of SREBP1c expression in the liver
Li, S., Ogawa, W., Emi, A., Hayashi, K., Senga, Y., Nomura, K., Hara, K., Yu, D., & Kasuga, M. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.07.038 · Cited by 84 · cited 1×
“AKT has been reported to modulate the mTORC1-S6K1 pathway to regulate SREBP-1c expression in the liver [97].”
BackgroundLipid Sensing and Insulin Resistance in the Brain
Yue, J. T. Y., & Lam, T. K. T. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.01.013 · Cited by 83 · cited 2×
“second, brain insulin action is attenuated or even diminished in response to both endogenous and exogenous insulin stimulation [133], which impairs hypothalamic AKT activation due to ER stress and the activation of inflammatory pathways [134].”
BackgroundDornan, G. L., & Burke, J. E. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00575 · Cited by 83
A Noncanonical, GSK3-Independent Pathway Controls Postprandial Hepatic Glycogen Deposition
Wan, M., Leavens, K. F., Hunter, R. W., Koren, S., von Wilamowitz-Moellendorff, A., Lu, M., Satapati, S., Chu, Q., Sakamoto, K., Burgess, S. C., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.06.001 · Cited by 81 · cited 3×
“[161] C57BL/6 mice HepG2 cell glycerol kinase (Gyk) Decreases the expression of FoxO1 reduced expression of G6Pase and PEPCK [162] C57BL/6 mice NPC1L1 Regulates the AKT-FOXO1-PEPCK/G6Pase pathway reduced expression of G6Pase and PEPCK [163] MCF7-tet OFF Sesn2F cells Sestrins (Sesn1/2/3) through activation of AMPK and…”
BackgroundInfluentialCantley, J., Choudhury, A. I., Asare‐Anane, H., Selman, C., Lingard, S. J., Heffron, H., Herrera, P. L., Persaud, S. J., & Withers, D. J. (2007) · Diabetologia · doi:10.1007/s00125-007-0637-9 · Cited by 79 · cited 1×
“β cell-specific knockout of IRS2 or the IR, which disrupts of insulin signalling in pancreatic β cells, reduces the pancreatic insulin content, β cell mass and glucose-stimulated insulin secretion, followed by the development of a phenotype similar to T2DM [140, 141].”
Cellular Regulation of Glucose Uptake by Glucose Transporter GLUT4
Govers, R. (2014) · Advances in clinical chemistry · doi:10.1016/b978-0-12-801401-1.00006-2 · Cited by 78 · cited 1×
“And the direct target of AKT is a substrate of 160 kDa (AS160), also known as TBC1D1 [29].”
BackgroundJazet, I. M., Schaart, G., Gastaldelli, A., Ferrannini, E., Hesselink, M. K. C., Schrauwen, P., Romijn, J. A., Maassen, J. A., Pijl, H., Ouwens, D. M., et al. (2007) · Diabetologia · doi:10.1007/s00125-007-0862-2 · Cited by 73 · cited 1×
“In early studies, insulin resistance was thought to be accompanied by excessive intramyocellular lipid (IMCL) levels [49], and improved insulin sensitivity observed in subjects with T2DM by reduced IMCL levels [50].”
BackgroundRanjit, S., Boutet, E., Gandhi, P., Prot, M., Tamori, Y., Chawla, A., Greenberg, A. S., Puri, V., & Czech, M. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m008771 · Cited by 73 · cited 1×
“How does insulin resistance occur in adipose tissues? The synthesis and secretion of adiponectin, tumour necrosis factor-α (TNF-α) and interleukin 6 (IL-6), which enhance lipolysis by reducing perilipin and fat-specific protein 27 levels [76].”
BackgroundBae, E. J., Xu, J., Oh, D. Y., Bandyopadhyay, G. K., Lagakos, W., Keshwani, M. M., & Olefsky, J. M. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.365544 · Cited by 70 · cited 1×
“In the feeding state, SREBP-1c is regulated by four pathways: activated AKT stimulates liver X receptor (LXR), which is require for SREBP-1c transcription [64]; activated AKT stimulates mTORC1 to activate SREBP-1c transcription, and mTORC1 also inhibits Lipin-1, which decreases the half-life of nuclear SREBP-1c [65, 6…”
BackgroundBanks, A. S., Kim-Muller, J. Y., Mastracci, T. L., Kofler, N. M., Qiang, L., Haeusler, R. A., Jurczak, M. J., Laznik, D., Heinrich, G., Samuel, V. T., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.09.012 · Cited by 70 · cited 1×
“The role of FoxO1 in liver lipid metabolism is less well studied; some studies have shown that FoxO1 is directly associated with insulin-promoted expression of fat genes in the liver, whereas others have reported a permissive role for FoxO1 in these processes [100-102].”
BackgroundSmith, M. A., Katsouri, L., Irvine, E. E., Hankir, M. K., Pedroni, S. M. A., Voshol, P. J., Gordon, M. W., Choudhury, A. I., Woods, A., Vidal‐Puig, A., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.03.029 · Cited by 68 · cited 1×
“One way to regulate HGP is that S6K1, a downstream molecule of mTOR1, regulates HGP, modulates neuronal excitability and peripheral lipid metabolism in POMC neurons, regulates the insulin sensitivity of skeletal muscle via AgRP neurons [128].”
BackgroundEndomembrane PtdIns(3,4,5)P3 activates the PI3K-Akt pathway
Jethwa, N., Chung, G. H. C., Lete, M. G., Alonso, A., Byrne, R. D., Calleja, V., & Larijani, B. (2015) · Journal of Cell Science · doi:10.1242/jcs.172775 · Cited by 68 · cited 1×
“Recently, endomembranes that contain PIP3 and PIP2 have also been shown to directly contribute to AKT activation [25, 26].”
BackgroundPDK-1/FoxO1 pathway in POMC neurons regulatesPomcexpression and food intake
Iskandar, K., Cao, Y., Hayashi, Y., Nakata, M., Takano, E., Yada, T., Zhang, C., Ogawa, W., Oki, M., Chua, S. C., et al. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00512.2009 · Cited by 67 · cited 1×
“In response to insulin resistance in the brain, overexpression of FoxO1 in POMC neurons leads to obesity and hyperphagia [136].”
BackgroundZhuo, S., Yang, M., Zhao, Y., Chen, X., Zhang, F., Li, N., Yao, P., Zhu, T., Mei, H., Wang, S., et al. (2016) · Diabetes · doi:10.2337/db16-0166 · Cited by 67
Vary, T., Jefferson, L., & Kimball, S. (2001) · American Journal of Physiology. Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.5.e1045 · Cited by 64 · cited 1×
“In skeletal muscle, insulin stimulates protein synthesis and accelerates mRNA translation by regulating the initiation steps of protein translation [42].”
BackgroundWang, X., & Hai, C. (2011) · Mini-Reviews in Medical Chemistry · doi:10.2174/138955711797247761 · Cited by 63
Wang, C., Chen, Z., Li, S., Zhang, Y., Shi, J., Li, J., Chi, Y., Miao, Y., Guan, Y., & Yang, J. (2013) · Diabetes · doi:10.2337/db13-1096 · Cited by 63
Chattopadhyay, T., Singh, R. R., Gupta, S., & Surolia, A. (2017) · BioFactors · doi:10.1002/biof.1334 · Cited by 60 · cited 1×
“promotes peripheral insulin resistance [156]”
Ramnanan, C. J., Edgerton, D. S., & Cherrington, A. D. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.03.006 · Cited by 56 · cited 2×
“Third, insulin functions through the AKT pathway suppress α-cell glucagon secretion in the brain, which reducing HGP levels in the liver [92, 95, 96].”
BackgroundDisruption of Adipose Rab10-Dependent Insulin Signaling Causes Hepatic Insulin Resistance
Vazirani, R. P., Verma, A., Sadacca, L. A., Buckman, M. S., Picatoste, B., Beg, M., Torsitano, C., Bruno, J., Patel, R. T., Šimonytė, K., et al. (2016) · Diabetes · doi:10.2337/db15-1128 · Cited by 55 · cited 1×
“For example, specifically knockdown of GLUT4 in adipose tissues resulted in insulin resistance in skeletal muscle and liver instead of adipose tissues [74].”
BackgroundLiu, Y., Vertommen, D., Rider, M. H., & Lai, Y. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.05.005 · Cited by 53 · cited 1×
“AKT-mediated mTORC1 activation regulates a number of downstream effectors proteins through phosphorylation, including the well-characterized effectors p70 ribosomal S6 protein kinase-1 (S6K1) and eukaryotic translation initiation factor-4E (eIF4E)binding protein-1 (4E-BP1), to increase protein synthesis [43, 44].”
BackgroundGlial Cell Line-Derived Neurotrophic Factor Increases β-Cell Mass and Improves Glucose Tolerance
Mwangi, S. M., Anitha, M., Mallikarjun, C., Ding, X., Hara, M., Parsadanian, A. S., Larsen, C. P., Thulé, P. M., Sitaraman, S. V., Anania, F. A., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2007.12.033 · Cited by 51
Gpr17 in AgRP Neurons Regulates Feeding and Sensitivity to Insulin and Leptin
Ren, H., Cook, J. R., Kon, N., & Accili, D. (2015) · Diabetes · doi:10.2337/db15-0390 · Cited by 51
Ahmad, F., Lindh, R., Tang, Y., Ruishalme, I., Öst, A., Sahachartsiri, B., Strålfors, P., Degerman, E., & Manganiello, V. (2009) · Biochemical Journal · doi:10.1042/bj20090842 · Cited by 50 · cited 1×
“AKT-independent, PI3K-dependent pathway also regulates adipocyte lipolysis by directly regulating PKA [72], AKT regulate FoxO1 through three pathway: reducing the expression of the rate-limiting lipolytic enzyme (ATGL), which is responsible for triacylglycerol hydrolase activity (ATGL) [62]; reducing the expression of…”
BackgroundInhibiting or antagonizing glucagon: making progress in diabetes care
Lefèbvre, P. J., Paquot, N., & Scheen, A. J. (2015) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12480 · Cited by 45 · cited 1×
“Third, insulin functions through the AKT pathway suppress α-cell glucagon secretion in the brain, which reducing HGP levels in the liver [92, 95, 96].”
BackgroundTargeting type 2 diabetes: lessons from a knockout model of insulin receptor substrate 2
Oliveira, J. M., Rebuffat, S. A., Gasa, R., & Gomis, R. (2014) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2014-0114 · Cited by 43
Interleukin-1 effect on glycemia in the non-obese diabetic mouse at the pre-diabetic stage.
Amrani, A., Jafarian-Tehrani, M., Morméde, P., Durant, S., Pléau, J., Haour, F., Dardenne, M., & Homo-Delarche, F. (1996) · Journal of Endocrinology · doi:10.1677/joe.0.1480139 · Cited by 40 · cited 1×
“The increased in subjects with obesity-induced inflammation, aggravating insulin resistance [77].”
BackgroundMiller, A. M., Brestoff, J. R., Phelps, C. B., Berk, E. Z., & Reynolds, T. (2008) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.90428.2008 · Cited by 35 · cited 1×
“According to a recent study, mTOR1 is dispensable for the regulation of feeding behaviour and energy metabolism [124], and chronic activation of mTOR1 interferes with the hypothalamic neurons that regulate feeding and energy balance [125].”
BackgroundPHLPP: a putative cellular target during insulin resistance and type 2 diabetes
Mathur, A., Pandey, V. K., & Kakkar, P. (2017) · Journal of Endocrinology · doi:10.1530/joe-17-0081 · Cited by 34
Wang, W., Liu, Y., Chen, Y., Cao, C.-P., Xiang, Y., Zhang, D., Han, L., Zhao, H., & Liu, G. (2009) · Peptides · doi:10.1016/j.peptides.2009.11.011 · Cited by 27 · cited 1×
“In addition, the PI3K/AKT pathway prevents lipotoxicity in pancreatic β cells by inhibiting FoxO1, which is abundantly expressed in pancreatic β cells and promotes FFA-induced β cell apoptosis [146, 147].”
BackgroundSelf-citationMottaghi, S., Larijani, B., & Sharifi, A. (2012) · Medical Hypotheses · doi:10.1016/j.mehy.2012.08.007 · Cited by 25
Phosphoinositide 3‐kinase: a new kid on the block in vascular anomalies
Castillo, S. D., Vanhaesebroeck, B., & Sebire, N. J. (2016) · The Journal of Pathology · doi:10.1002/path.4802 · Cited by 24 · cited 1×
“RTKs recruit class I PI3Ks to the plasma membrane, which relieves the inactivation function of p85 and p110 to activate the protein [12, 13].”
BackgroundAlbert, V., Cornu, M., & Hall, M. (2015) · Biochemical and Biophysical Research Communications - BBRC · doi:10.1016/j.bbrc.2015.06.161 · Cited by 20
Dapper1 attenuates hepatic gluconeogenesis and lipogenesis by activating PI3K/Akt signaling
Kuang, J.-R., Zhang, Z., Leng, W., Lei, X., & Liang, Z. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.02.028 · Cited by 20
Kurano, M., Hara, M., Satoh, H., & Tsukamoto, K. (2015) · Metabolism · doi:10.1016/j.metabol.2015.01.011 · Cited by 18
Flagged first, then by citations
4 of the 171 references couldn’t be matched to a known paper.
Research works printed but not linked: 5
- [98]Yecies Jessica L Zhang Hui H Menon S Liu S Yecies D Lipovsky Alex I Akt Stimulates Hepatic SREBP1c and Lipogenesis through Parallel mTORC1-Dependent and Independent Pathways Cell metabolism 2011 14 1 21 32 21723501 PMC3652544
- [120]Al-Qassab H Smith MA Irvine EE Guillermet-Guibert J Claret M Choudhury AI Dominant role of the p110beta isoform of PI3K over p110alpha in energy homeostasis regulation by POMC and AgRP neurons Cell metabolism 2009 10 5 343 54 19883613 PMC2806524
- [144]Bernal-Mizrachi E Wen W Stahlhut S Welling CM Permutt MA Islet beta cell expression of constitutively active Akt1/PKB alpha induces striking hypertrophy, hyperplasia, and hyperinsulinemia J Clin Invest 2001 108 11 1631 8 11733558 PMC200992
- [147]Wang HW Mizuta M Saitoh Y Noma K Ueno H Nakazato M Glucagon-like peptide-1 and candesartan additively improve glucolipotoxicity in pancreatic beta-cells Metabolism 2011 60 8 1081 9 21255808
- [161]Villani V Milanesi A Sedrakyan S Da Sacco S Angelow S Conconi MT Amniotic fluid stem cells prevent beta-cell injury Cytotherapy 2014 16 1 41 55 24210784 PMC4374982
Cited by
Sorted by citations
Signaling pathways in obesity: mechanisms and therapeutic interventions
Wen, X., Zhang, B., Wu, B., Xiao, H., Li, Z., Li, R., Xu, X., & Li, T. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01149-x · Cited by 490
The gluconeogenic enzyme PCK1 phosphorylates INSIG1/2 for lipogenesis
Xu, D., Wang, Z., Xia, Y., Shao, F., Xia, W., Wei, Y., Li, X., Qian, X., Lee, J.-H., Du, L., et al. (2020) · Nature · doi:10.1038/s41586-020-2183-2 · Cited by 360
Targeting PI3K/AKT signaling pathway in obesity.
Savova, M., Mihaylova, L., Tews, D., Wabitsch, M., & Georgiev, M. (2023) · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · doi:10.1016/j.biopha.2023.114244 · Cited by 260
The PI3K/Akt Pathway in Meta-Inflammation
Acosta‐Martínez, M., & Cabail, M. Z. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315330 · Cited by 259
“Akt1 is ubiquitously expressed, whereas Akt2 is mainly expressed in insulin-sensitive tissues, such as AT, liver and skeletal muscle, and Akt3 is expressed in the brain and the testes [25].”
BackgroundInsulin Signal Transduction Perturbations in Insulin Resistance
Khalid, M., Alkaabi, J., Khan, M. A. B., & Adem, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168590 · Cited by 233
Metadata
- Authors
- Huang, X., Liu, G., Guo, J., & Su, Z.
- Affiliations
- Guangdong Pharmaceutical University (CN)
- Shenzhen Center for Disease Control and Prevention (CN)
- Corresponding author
- Guo, Jiao
- Su, Zhengquan
- Venue
- International Journal of Biological Sciences
- Publisher
- Ivyspring International Publisher
- Published
- 2018
- Volume
- 14
- Issue
- 11
- Pages
- 1483-1496
- ISSN
- 1449-2288 (ISSN-L)
- PMC
- PMC6158718
- OpenAlex
- W2886504687
- Cited by
- 1,673
- References
- 171
- Citations by year
- 2026: 197 · 2025: 296 · 2024: 282 · 2023: 258 · 2022: 246 · 2021: 211 · 2020: 136 · 2019: 44 · 2018: 3
- FWCI
- 9.71
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- Locations
- International Journal of Biological Sciences (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (2017-02, 81173107)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- PI3K/Akt signaling, obesity, type 2 diabetes, insulin resistance, hyperglycemia, skeletal muscle, adipose tissue, liver, pancreas, therapeutic target, metabolic disorders
- MeSH terms
- Animals, Diabetes Mellitus, Type 2, Humans, Insulin Resistance, Obesity, Signal Transduction, Phosphatidylinositol 3-Kinases, Proto-Oncogene Proteins c-akt
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review